AI Verdict
RES has stronger fundamentals based on our AI analysis.
RES vs RENXF Fundamental Comparison
| Metric | RES | RENXF |
|---|---|---|
| Revenue | $1.6B | $522,000.0 |
| Net Income | $32.1M | $-4.7M |
| Net Margin | 2.0% | -905.7% |
| ROE | 2.9% | N/A |
| ROA | 2.2% | -98.6% |
| Current Ratio | 3.24x | 0.24x |
| Debt/Equity | 0.00x | N/A |
| EPS | $0.15 | $-0.04 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RES vs RENXF: Frequently Asked Questions
Is RES or RENXF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RES has stronger fundamentals. RES is rated SELL (68% confidence) while RENXF is rated STRONG SELL (95% confidence). This is not investment advice.
How does RES compare to RENXF fundamentally?
RPC INC has ROE of 2.9% vs Renalytix plc's N/A. Net margins are 2.0% vs -905.7% respectively.
Which stock pays higher dividends, RES or RENXF?
RES has a dividend yield of N/A or no dividend while RENXF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RES or RENXF for long term?
For long-term investing, consider that RES has SELL rating with 68% confidence, while RENXF has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RES vs RENXF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RES vs RENXF, the AI consensus favors RES based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.